Monday, December 23, 2024
HomeTagsBVX-1021

BVX-1021

BioVaxys Sarbecovirus Vaccine Interim Data Excellent Emerging Safety & Tolerability

BioVaxys Technology Corp. is pleased to announce that interim results from its ongoing preclinical of BVX-1021, the Company's vaccine for SARS-CoV-1 ("SARS1") which is...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics